GAINESVILLE, Fla., July 13 -- Hispanic women with coronary artery disease and hypertension achieved better blood pressure control than non-Hispanic white counterparts who were treated with the same antihypertensive drugs.
The finding emerged from a post hoc analysis of data from the INVEST trial that compared a calcium channel-blocker-based regimen to a beta-blocker-based regimen, Rhonda M. Cooper-DeHoff, Pharm., D., of the University of Florida, and colleagues, reported in the June issue of the Journal of Women's Health.
They found that 75% of Hispanic women achieved blood pressure control versus 68% of non-Hispanic white women (P<0.001).
Non-Hispanic women were also significantly less likely to have a first heart attack, a nonfatal stroke, or die from any cause during 24 months follow-up (HR 0.84, 95% CI, 0.71-0.98 P=0.03).
